Revenue

Niche's 2026 rankings reveal a major shift: Americans are choosing smaller, walkable communities that blend urban access with neighborhood charm.

With a new $40M loan, Hyperfine is set to accelerate the rollout of its Swoop® system, bringing AI-powered brain imaging directly to the patient's bedside.

A new collaboration aims to solve antibody reproducibility, promising to enhance diagnostic accuracy and accelerate the future of precision oncology.

New research reveals a startling link between common liver conditions and heart failure in older adults with atrial fibrillation, urging a new look at risk.

Sydnexis's eye drop trial shows high efficacy in children 3-12, positioning it as a potential first-of-its-kind FDA-approved drug for myopia.

A new $16B Texas power plant, part of a U.S.-Japan deal, aims to fuel the data center boom without raising consumer bills. Can this massive project succeed?

Tempest Therapeutics raises up to $6M in a critical financing deal to advance its CAR-T pipeline, balancing promising clinical data with financial pressures.

The bioconjugate CRDMO reports record profits and a $1.49B backlog, fueled by tech innovation, strategic acquisitions, and global expansion.

Ephicacy appoints biometrics SVP Jamie Powers and India Head Tyagi Swaminathan in a strategic push to dominate advanced clinical trial analytics.

Following the Baker Tilly merger, Moss Adams' wealth unit launches as Threadline Wealth, an independent RIA backed by Cynosure to target HNW clients.

A key preclinical success in a $570M partnership advances a novel therapy designed to reset the immune system for patients with lupus, MS, and arthritis.

The new "Dataminr for Cyber Defense" leverages agentic AI to fuse external threats with internal data, aiming to operationalize Gartner's security vision.

At RSA Conference 2026, SOCRadar launched an AI Agent Marketplace and identity intelligence tools to combat the surge in credential-based cyberattacks.

Nearly 200 Michigan lottery ticket workers secured record raises and benefits, signaling a major power shift in the national printing industry.

An investor turns an office building into 14 alternative assets, showcasing a complex 1031 exchange strategy driven by state housing mandates and market shifts.

With a new CEO and President set to take over in 2026, Oakbridge Insurance is doubling down on its growth-by-acquisition and producer-centric model.

Ontic's new platform replaces outdated spreadsheets and radios with a unified, data-driven system for real-time, defensible physical security response.

A new AI-native platform aims to transform messy security data, promising to boost analyst efficiency and cut costs in the era of agentic AI.

Facing a $35.7M loss and crippling 45% tariffs, Conifex Timber secures a lifeline loan while warning it may not survive the ongoing trade war.

Lifecore Biomedical secures its third major manufacturing deal in five months, signaling a strategic shift that could reshape the aesthetics supply chain.